scholarly journals Oral health and longitudinal changes in fasting glucose levels: A nationwide cohort study

PLoS ONE ◽  
2021 ◽  
Vol 16 (6) ◽  
pp. e0253769
Author(s):  
Tae-Jin Song ◽  
Yoonkyung Chang ◽  
Jimin Jeon ◽  
Jinkwon Kim
Keyword(s):  
Oral Health ◽  
Glucose Level ◽  
Standard Error ◽  
Tooth Loss ◽  
Fasting Glucose ◽  
Screening Program ◽  
Health Screening ◽  
Tooth Brushing ◽  
Fasting Glucose Level ◽  
Glucose Levels

We investigated the association between oral hygiene indicators of periodontitis, tooth loss, and tooth brushing on the longitudinal fasting glucose level in non-diabetic subjects. Using a nationwide health screening database in Korea, we included non-diabetic individuals who received a health screening program with oral health check in 2009–2010. We constructed a linear mixed model for the longitudinal data of fasting glucose from the baseline to 2015. During the 4.84-year of median follow-up, 91,963 individuals (mean age 56.2 at baseline) underwent 392,780 health examinations with fasting glucose level (mmol/L). The presence of periodontitis was 39.3%. In the multivariate linear mixed analysis, periodontitis was related with increased fasting glucose levels (β = 0.0084, standard error = 0.0035, p = 0.018). Similarly, tooth loss was associated with increased level of fasting glucose (β = 0.0246, standard error = 0.0038, p < 0.001). Compared with tooth brushing ≤2 times/day, tooth brushing ≥3 times/day was associated with decreased fasting glucose levels (β = -0.0207, standard error = 0.0033, p < 0.001). Our data showed that periodontitis and tooth loss were associated with increased fasting glucose levels in non-diabetic individuals. The study findings imply that frequent tooth brushing may reduce fasting glucose levels. Further research is needed to determine the effect of periodontal intervention on glycemic control.

scholarly journals The Incremental Risk of Pancreatic Cancer According to Fasting Glucose Levels: Nationwide Population-Based Cohort Study

2019 ◽  
Vol 104 (10) ◽  
pp. 4594-4599 ◽  
Author(s):  
Dong-Hoe Koo ◽  
Kyung-Do Han ◽  
Cheol-Young Park
Keyword(s):  
Pancreatic Cancer ◽  
Glucose Level ◽  
Cumulative Incidence ◽  
Fasting Glucose ◽  
Population Based ◽  
Incidence Rates ◽  
Fasting Glucose Level ◽  
Glucose Levels ◽  
Level 1 ◽  
Level 2

Abstract Context It has been unclear whether the risk of pancreatic cancer is different according to glucose levels. Objective To determine the association between fasting glucose levels and pancreatic cancer risk using prospectively collected nationwide population-based cohort data in Korea. Design The National Health Insurance Service database of claims and preventive health check-up data recorded was used between 2009 and 2015. Setting and Participants A total of 25.4 million patients who had participated in a preventive health check-up between 2009 and 2013 were evaluated for pancreatic cancer incidence rates according to fasting glucose level. Main Outcomes Measures The cumulative incidence rate for pancreatic cancer was calculated after grouping according to fasting glucose levels as follows: (i) low normal (<90 mg/dL), (ii) high normal (90 to 99 mg/dL), (iii) prediabetes level 1 (100 to 109 mg/dL), (iv) prediabetes level 2 (110 to 125 mg/dL), (v) diabetes (≥126 mg/dL), and (vi) diabetes on anti-diabetic medications. Results The 5-year cumulative incidence rates (per 100,000) were as follows: (i) low normal = 32; (ii) high normal = 41; (iii) prediabetes level 1 = 50; (iv) prediabetes level 2 = 64; (v) diabetes = 75; and (vi) on anti-diabetic medications = 121. The risk of pancreatic cancer increased continuously with elevating fasting glucose levels (P < 0.0001). The incidence of pancreatic cancer increased significantly with increasing fasting blood glucose levels even after adjusting for age, sex, smoking, drinking, exercise, body mass index, and diabetes duration (P < 0.0001). Conclusions The cumulative incidence rate of pancreatic cancer significantly increased as the fasting glucose level elevated, even in populations with a normal glucose level range.

scholarly journals Association between Findings in Oral Health Screening and Body Mass Index: A Nation-Wide Longitudinal Study

2021 ◽  
Vol 18 (21) ◽  
pp. 11062
Author(s):  
Yoonkyung Chang ◽  
Jimin Jeon ◽  
Jin-Woo Kim ◽  
Tae-Jin Song ◽  
Jinkwon Kim
Keyword(s):  
Body Mass Index ◽  
Oral Health ◽  
Dental Caries ◽  
Body Mass ◽  
Oral Hygiene ◽  
Tooth Loss ◽  
Mixed Model ◽  
Linear Mixed Model ◽  
Health Screening ◽  
Tooth Brushing

Oral diseases, such as periodontitis and dental caries, can cause systemic inflammation as well as local effects, which is an important contributing factor for obesity. We aimed to investigate the change in body mass index (BMI) according to the presence of periodontitis and oral hygiene indicators. This study enrolled 110,068 participants from the national health screening cohort in Korea from 2009–2010 who underwent an oral health checkup. As oral hygiene indicators, the presence of periodontitis, dental caries, tooth loss, and tooth brushing were assessed. We constructed a linear mixed model for BMI. BMI was repeatedly measured in the health examination until 2015. In the multivariate linear mixed model for BMI, the presence of periodontitis (β = 0.0687, standard error (SE) = 0.0225, p = 0.002), dental caries (β = 0.0735, SE = 0.0152, p < 0.001), and tooth loss (β = 0.1328, SE = 0.0175, p < 0.001) were positively associated with BMI. In contrast, frequent tooth brushing (≥3 times/day) was negatively associated with BMI (β = −0.2610, SE = 0.0306, p < 0.001). The presence of periodontitis, dental caries, and tooth loss may be associated with higher BMI, whereas frequent tooth brushing may be related to lower BMI. Better oral hygiene might be associated with lower BMI. Further study is needed to determine the effect of oral health behavior and dental disease on obesity.

scholarly journals Association of the brain-derived neurotrophic factor Val66Met polymorphism with body mass index, fasting glucose levels and lipid status in adolescents

2020 ◽  
Vol 23 (1) ◽  
pp. 77-82
Author(s):  
V Vidović ◽  
N Maksimović ◽  
I Novaković ◽  
T Damnjanović ◽  
B Jekić ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Blood Glucose ◽  
Lipid Profile ◽  
Body Mass ◽  
Glucose Level ◽  
Neurotrophic Factor ◽  
Fasting Glucose ◽  
Fasting Glucose Level ◽  
Val66met Polymorphism ◽  
Glucose Levels

AbstractBrain-derived neurotrophic factor (BDNF) has an important role in energy balance. It suppresses food intake, reduces hepatic glucose production and converts white fat into brown fat in adipose tissue, leading to energy dissipation, lowered blood glucose and a lean phenotype. Studies have shown that the single nucleotide polymorphism (SNP) Val66Met within BDNF may be associated with obesity, insulin sensitivity, type 2 diabetes mellitus (T2DM) and dyslipidemia. The objective of the study was to investigate the association of the Val66Met polymorphism with body mass index (BMI), fasting glucose levels and lipid profile in Serbian adolescents. The study included 308 randomly selected healthy adolescents, 153 (49.68%) boys and 155 girls (50.32%), 15 years of age. Data including age, gender, height, weight, lipid profile and fasting glucose were recorded. Genotyping was performed by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. No association of this polymorphism was found with BMI and lipid profile. However, significant association was observed between this polymorphism and fasting blood glucose (FBG). Carriers of a Val/Val genotype had significantly higher mean values of fasting glucose level compared to carriers of Val/ Met and Met/Met genotypes (p = 0.01). To confirm these results multiple linear regression analysis was performed. Body mass index and gender were taken as covariates. Carriers of the Val/Val genotype had significantly higher levels of FBG (β = -0.152, p = 0.02). A statistically significant association between BMI and glucose level was also observed (β = 0.124,p = 0.033). This polymorphism could be associated with fasting glucose level in Serbian adolescents, thus further research would be of great interest to validate these results.

scholarly journals Long-term Absolute Risk for Cardiovascular Disease Stratified by Fasting Glucose Level

Diabetes Care ◽  
2019 ◽  
Vol 42 (3) ◽  
pp. 457-465 ◽  
Author(s):  
Michael P. Bancks ◽  
Hongyan Ning ◽  
Norrina B. Allen ◽  
Alain G. Bertoni ◽  
Mercedes R. Carnethon ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Glucose Level ◽  
Fasting Glucose ◽  
Absolute Risk ◽  
Fasting Glucose Level

scholarly journals GENE POLYMORPHISM ANALYSIS OF CHEMOKINES, CHEMOKINE RECEPTORS, ACUTE PHASE PROTEINS, AND CD14 IN FEMALE OBESITY DEVELOPMENT

2018 ◽  
Vol 20 (5) ◽  
pp. 739-746
Author(s):  
O. V. Kochetova ◽  
L. Z. Akhmadishina ◽  
G. F. Korytina ◽  
Т. V. Victorova
Keyword(s):  
Body Weight ◽  
Glucose Level ◽  
Acute Phase ◽  
Chemokine Receptors ◽  
Acute Phase Proteins ◽  
Fasting Glucose ◽  
Polymorphic Locus ◽  
Control Group ◽  
Polymorphism Analysis ◽  
Fasting Glucose Level

In the present study, we have investigated frequency of genotypes and functional alleles of genes encoding chemokines (CXCL12 rs1801157, CCL2 rs1024611), chemokine receptors (CCR5 del32, CX3CR1 rs3732378), acute phase proteins SAA rs1136743, and CD14 rs2569190 polymorphisms among Tatar obese or overweight women from the Republic of Bashkortostan.The group of patients comprised unrelated women with obesity (BMI ≥ 30 kg/m2, n = 225), females with overweight (BMI 25.0-29.9 kg/m2, n = 184), and control group of women (n = 327) BMI < 25.0 kg/m2. Genotyping was performed by PCR-RFLP analysis. Patients and controls differed in such parameters as body weight (p = 0.00001), BMI level (p = 0.001) and fasting glucose level (p = 0.0001).An association was revealed between obesity andAG-AAgenotypes (p = 0.007) andAallele (p = 0.003) of polymorphic locus rs3732378 ofCXCR1gene, as well asTTgenotype (p = 0.027) andTallele (p = 0.021) of polymorphic locus rs1136743 ofSAAgene. It has been shown that theAAgenotype of polymorphic locus rs3732378 of theCX3CR1gene is associated with increased body weight (p = 0.002) and elevated BMI (p = 0.018); theGGgenotype of polymorphic locus rs1024611 of theCCL2gene is associated with elevated fasting glucose level (p = 0.001).As based on clinical and genetic data and using logistic regression, some statistically significant differences were revealed, which allow to predict development of obesity in Tatar women.

scholarly journals Association of impaired fasting glucose and Type 2 Diabetes Mellitus with brain volume changes in Alzheimer’s Disease patients analyzed by MRI: a retrospective study

PeerJ ◽  
2020 ◽  
Vol 8 ◽  
pp. e9801
Author(s):  
Weiwei Wang ◽  
Leongtim Wong ◽  
Lin Shi ◽  
Yishan Luo ◽  
Zhanhua Liang ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glucose Level ◽  
Brain Volume ◽  
Fasting Glucose ◽  
Fasting Glucose Level ◽  
Volume Changes ◽  
Brain Volumes

Objectives Alzheimer’s disease (AD), impaired fasting glucose (IFG), and Type 2 diabetes mellitus (T2DM) were reported associated with smaller brain volumes. Nevertheless, the association of hyperglycemia with brain volume changes in AD patients remains unclear. To investigate this issue, structural magnetic resonance imaging was used to compare brain volumes among AD patients with different fasting glucose levels. Methods Eighty-five AD patients were divided into three groups based on their fasting glucose level as suggested by the American Diabetes Association: normal fasting glucose group (AD_NFG, n = 45), AD_IFG group (n = 15), and AD_T2DM group (n = 25). Sagittal 3D T1-weighted images were obtained to calculate the brain volume. Brain parenchyma and 33 brain structures were automatically segmented. Each regional volume was analyzed among groups. For regions with statistical significance, partial correlation analysis was used to evaluate their relationships with fasting glucose level, corrected for Mini-Mental State Examination score, age, education level, cholesterol, triglyceride, and blood pressure. Results Compared with the AD_IFG and AD_NFG groups, the volume of pons in AD_T2DM group was significantly smaller. Fasting glucose was negatively correlated with pontine volume. Conclusions T2DM may exacerbate pontine atrophy in AD patients, and fasting glucose level is associated with pontine volume.

scholarly journals Evaluation of genetic risk related to high fasting glucose level in the Hungarian Roma population

2015 ◽  
Vol 25 (suppl_3) ◽  
Author(s):  
Sz Fiatal ◽  
V Tomori ◽  
P Pikó ◽  
Á Moravcsik-Kornyicki ◽  
B Soltész ◽  
...  
Keyword(s):  
Glucose Level ◽  
Genetic Risk ◽  
Fasting Glucose ◽  
Fasting Glucose Level ◽  
Roma Population ◽  
High Fasting Glucose

Peptide receptor radionuclide therapy as a tool for the treatment of severe hypoglycemia in patients with primary inoperable insulinoma

2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Marta Opalińska ◽  
Anna Sowa-Staszczak ◽  
Ibraheem Al Maraih ◽  
Aleksandra Gilis-Januszewska ◽  
Alicja Hubalewska-Dydejczyk
Keyword(s):  
Glucose Level ◽  
Fasting Glucose ◽  
Hepatic Metastases ◽  
Peptide Receptor Radionuclide Therapy ◽  
Severe Hypoglycemia ◽  
Insulin Level ◽  
Line Treatment ◽  
Second Line ◽  
Fasting Glucose Level ◽  
Curative Surgery

Abstract Objectives Severe hypoglycemia in a course of inoperable insulinoma may be life-threating and often it is not well controlled, even by high doses of diazoxide requiring second line treatment. Among available methods PRRT is characterized by relatively low toxicity and is connected with favorable antitumor effect. The aim of the study was an evaluation of the PRRT effectiveness in control of hypoglycemia in patients with primary inoperable insulinoma. Methods Three patients (female with metastatic insulinoma, male with primary inoperable pancreatic tumor, female with MEN1 syndrome and hepatic metastases) were treated with PRRT due to severe hypoglycemia poorly controlled by diazoxide in course of primary inoperable insulinoma. Results Patient 1 baseline fasting glucose concentration increased from 2.4 mmol/L [3.30–5.60] to 5.9 mmol/L after PRRT. In patient 2 fasting glucose level 2.30 mmol/L increased after PRRT to 7.0 mmol/L, while baseline insulin level initially 31.15 uU/mL [2.6–24.9] decreased to 15.4 uU/mL. In patients 3, baseline fasting glucose level 2.5 mmol/L increased after PRRT to 7.9 mmol/L, and insulin decreased from 57.9 uU/mL to 6.3 uU/mL. In imaging there was partial response (PR) in patient 1 and 2 and stabilization of the tumor size in patient 3. In patient 2 reduction of tumor infiltration let for curative surgery performed 4 months after PPRT. Conclusions PRRT may be effective as a first or second line treatment in management of hypoglycemia for patients with hormonally active inoperable insulinoma.

Sign in / Sign up

Export Citation Format

Share Document